Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 1,865 across all filing types
Latest filing 2024-06-07 Proxy Solicitation & In…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于召开2024年第二次临时股东大会通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2024 second extraordinary general meeting of shareholders for a company, including meeting date, voting methods, agenda items (such as election of board members and approval of remuneration plans), voting instructions, and proxy forms. It does not contain financial statements or results, nor is it a transcript or presentation. It is a formal announcement of a shareholders meeting with agenda and voting details. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is about 4667 characters, which is consistent with a detailed meeting notice and proxy materials. Therefore, the classification is PSI with high confidence.
2024-06-07 Chinese
益丰药房关于职工代表监事换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of an employee representative supervisor to the company's supervisory board. It includes details about the election process, the elected individual's qualifications, and compliance with relevant laws and regulations. There is no financial data, no mention of annual or interim reports, no audit information, no earnings data, and no regulatory certifications. The content focuses on management/board composition changes, specifically the appointment of a supervisory board member. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2024-06-07 Chinese
独立董事提名人声明与承诺(黄纯安)
Board/Management Information Classification · 95% confidence The document is a formal statement from the board nominating an independent director candidate, detailing qualifications, independence criteria, and compliance with regulatory requirements. It is a nomination declaration rather than a report, financial statement, or announcement of voting results. It does not contain financial data, earnings, or meeting results. It is not a proxy solicitation or remuneration report. The content fits best under Board/Management Information (MANG) as it relates to board member nomination and governance matters.
2024-06-07 Chinese
益丰药房第四届监事会第三十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 33rd meeting of the 4th Supervisory Board of Yifeng Pharmacy Chain Co., Ltd. It details meeting attendance, voting results, and specific agenda items such as election nominations, remuneration plans, and stock repurchase adjustments. The content focuses on board-level decisions and governance matters rather than financial results, audit opinions, or shareholder voting outcomes. It is not a full annual or interim report, nor a call transcript or earnings release. The document is a governance-related announcement about board activities and decisions, fitting the category of Board/Management Information (MANG). The document length is short (1614 characters), and it contains substantive content about board resolutions, not just an announcement of a report publication or certification. Therefore, the classification is MANG with high confidence.
2024-06-07 Chinese
独立董事提名人声明与承诺 (王小岩)
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board, detailing qualifications, independence criteria, and compliance with regulatory requirements. It is a declaration related to board/management changes rather than a financial report, audit, or general regulatory filing. The content focuses on board nomination and independence confirmation, which aligns with announcements about board or management information.
2024-06-07 Chinese
益丰药房提名委员会议事规则
Governance Information Classification · 100% confidence The document is titled as the 'Nomination Committee Rules' of the Board of Directors of Yifeng Pharmacy Chain Co., Ltd. It details the composition, responsibilities, meeting procedures, and other governance-related rules for the nomination committee. There is no financial data, earnings information, or report publication announcement. The content focuses on governance structure and internal rules related to board and senior management nominations. Therefore, it fits best under Governance Information (CGR). The document length is 3247 characters, which is consistent with a detailed governance document rather than a brief announcement or a full annual report.
2024-06-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.